[144] BeOne Medicines Ltd. American SEC Filing

Rhea-AI Filing Summary

BeOne Medicines Ltd. (ONC) submitted a Form 144 proposing the sale of 89,794 ADS through Morgan Stanley Smith Barney LLC on NASDAQ, showing an aggregate market value of $25,869,651.40 and 54,564,278 ADS outstanding. The approximate sale date is 08/13/2025.

The filing states the ADS were acquired on 08/13/2025 by exercise of stock options from the issuer and paid in cash. It also lists prior common-share sales by Xiaobin Wu in June 2025: 1,363 (6/23/2025) for $354,380.00, 630 (6/17/2025) for $158,047.22, 1,543 (6/16/2025) for $409,694.43, and 1,934 (6/06/2025) for $489,590.94. The notice includes the standard representation that the filer does not possess undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider exercised options and filed to sell 89,794 ADS (~$25.9M) via Morgan Stanley on 08/13/2025.

The Form 144 discloses a proposed sale of 89,794 ADS with an aggregate market value of $25,869,651.40, to be executed through Morgan Stanley Smith Barney LLC on NASDAQ. The ADS were acquired the same day by exercise of stock options and paid for in cash. The filing also enumerates four prior common-share sales by Xiaobin Wu in June 2025 with stated gross proceeds. From a trading-impact perspective, the filing is a routine insider-sale disclosure; it documents intent to sell but does not include operational or earnings information.

Corporate Governance Expert

TL;DR: Form 144 documents option exercise and intended sale; prior June sales by the same individual are disclosed.

The document provides required Rule 144 disclosure: acquisition method (stock option exercise), payment in cash, and planned disposition details (broker, number of ADS, market value, exchange, approximate date). The filing includes prior transactions by Xiaobin Wu in June 2025, listing dates, amounts, and gross proceeds. The form contains the customary representation that the filer is unaware of undisclosed material adverse information. No signatures, notice dates, or issuer contact details are provided in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ADS	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	89794	25869651.40	54564278	08/13/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADS	08/13/2025	Exercise of Stock Options	Issuer			89794	08/13/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
XIAOBIN WU Aeschengraben 27, 21st Floor Basel V8 4051	Common	06/23/2025	1363	354380.00
XIAOBIN WU Aeschengraben 27, 21st Floor Basel V8 4051	Common	06/17/2025	630	158047.22
XIAOBIN WU Aeschengraben 27, 21st Floor Basel V8 4051	Common	06/16/2025	1543	409694.43
XIAOBIN WU Aeschengraben 27, 21st Floor Basel V8 4051	Common	06/06/2025	1934	489590.94

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ONC Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 89,794 ADS through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $25,869,651.40 and an approximate sale date of 08/13/2025.

How and when were the ADS being offered in the ONC filing acquired?

The ADS were acquired on 08/13/2025 by exercise of stock options from the issuer and payment was made in cash on the same date.

Who is the broker handling the proposed sale in the ONC Form 144?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services at 1 New York Plaza, 8th Floor, New York, NY 10004.

Has the filer sold company shares recently according to the filing?

Yes. The filing lists four common-share sales by Xiaobin Wu in June 2025: 1,363 on 06/23/2025 for $354,380.00, 630 on 06/17/2025 for $158,047.22, 1,543 on 06/16/2025 for $409,694.43, and 1,934 on 06/06/2025 for $489,590.94.

Does the Form 144 state whether the filer has material nonpublic information?

The filing includes the standard signer representation that the person does not know any material adverse information regarding the issuer that has not been publicly disclosed.